First-trimester screening for Down syndrome in singleton pregnancies achieved by intrauterine insemination

Journal of Assisted Reproduction and Genetics

Volumn 20, Issue 8, 2003, Pages 327-331

  Lai, Tsung Hsuan ^a   Chen, Su Chee ^a   Tsai, Ming Song ^a   Lee, Fa Kung ^a   Wei, Chi Feng ^a  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

Author keywords

Down syndrome; Intrauterine insemination; Ovulation induction; Screening

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; CLOMIFENE; HUMAN MENOPAUSAL GONADOTROPIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A; PROGESTERONE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; EMBRYO; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; HORMONE BLOOD LEVEL; HUMAN; INTRAUTERINE INSEMINATION; MATERNAL AGE; OVULATION INDUCTION; PRENATAL SCREENING; PRIORITY JOURNAL; RISK FACTOR; TAIWAN; THICKNESS;

ADULT; BODY WEIGHT; DOWN SYNDROME; FEMALE; GENETIC SCREENING; HUMANS; INSEMINATION, ARTIFICIAL; MATERNAL AGE; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS;

SAMBUCUS NIGRA CANADENSIS;

EID: 0041426302     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024813708875     Document Type: Article

References (18)

1. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K: Fetal nuchal translucency: Ultrasound screening for chromosomal defects in first trimester of pregnancy. Br Med J 1992;304:867-869
2. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH: UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Lancet 1998;352:343-346
3. Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH: A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-hCG and PAPP-A. Ultrasound Obstet Gynecol 1999;13:231-237
4. Spencer K, Liao AW, Skentou H, Cicero S, Nicolaides KH: Screening for triploidy by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 10-14 weeks of gestation. Prenat Diagn 2000;20:495-499
5. Spencer K, Spencer CE, Power M, Moakes A, Nicolaides KH: One stop clinic for assessment of risk for fetal anomalies: A report of the first year of prospective screening for chromosomal anomalies in the first trimester. Br J Obstet Gynecol 2000;107:1271-1275
6. Maymon R, Dreazen E, Weinraub Z, Bukovsky I, Herman A: Antenatal screening for Down's syndrome in assisted reproductive pregnancies. Hum Reprod Update 1999;5:530-534
7. Heinone S, Ryynanen M, Kirkinen P, Hippelainen M, Saarikoski S: Effect of in vitro fertilization on human chorionic gonadotropin serum concentrations and Down's syndrome screening. Fertil Steril 1996;66:398-403
8. Ribbert LS, Kornman LH, De Wolf BT, Simons AH, Jansen CA, Beekhuis JR, Mantingh A: Maternal serum screening for fetal down syndrome in IVF pregnancies. Prenat Diagn 1996;16:35-38
9. Wald NJ, White N, Morris JK, Huttly WJ, Canick JA: Serum markers for Down's syndrome in women who have had in vitro fertilization: Implications for antenatal screening. Br J Obstet Gynecol 1999;106:1304-1306
10. Barkai G, Goldman B, Ries L, Chaki R, Dor J, Cuckle H: Down's syndrome screening marker levels following assisted reproduction. Prenat Diagn 1996;16:1111-1114
11. Frishman GN, Canick JA, Hackett RJ, Kellner LH, Saller DN Jr: Serum triple marker screening in vitro fertilization and naturally conceived pregnancies. Obstet Gynecol 1997;90:98-101
12. Nicolaides KH, Brizot ML, Snijders RJ: Fetal nuchal translucency: Ultrasound screening for fetal trisomy in the first trimester of pregnancy. Br J Obstet Gynaecol 1994;101:782-786
13. Wald NJ, Hackshaw AK: Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome. Prenat Diagn 1997;17:821-829
14. Liao AW, Heath V, Kametas N, Spencer K, Nicolaides KH: First-trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction. Hum Reprod 2001;16:1501-1504
15. Maymon R, Dreazen E, Rozinsky S, Bukovsky I, Weinraub Z, Herman A: Comparison of nuchal translucency measurement and mid-gestation serum screening in assisted reproduction versus naturally conceived singleton pregnancies. Prenat Diagn 1999;19:1007-1011
16. Haddow JE, Palomaki GE, Knight GJ, Cunningham GC, Lustig LS: Maternal age-related Down syndrome detection and screening positive rate using the multiple marker screening test. In Williams Obstetrics, FG Cunningham, NF Gant, KJ Leveno, LC Gilstrap, III, JC Hauth, KD Wenstrom (eds), New York, Mcgraw-Hill, 2001, pp 984-985
17. Wojdemann KR, Larsen SO, Shalmi A, Sundberg K, Christiansen M, Tabor A: First trimester screening for Down syndrome and assisted reproduction: No basis for concern. Prenat Diagn 2001;21:563-565
18. Hsu TY, Ou CY, Hsu JJ, Kung FT, Chang SY, Soong YK: Maternal serum screening for Down syndrome in pregnancies conceived by intra-uterine insemination. Prenat Diagn 1999;19:1012-1014